PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS
Аbstract. Patients with end-stage renal disease need their kidney functions to be replaced. Chronic haemodialysis represents a most common method of such substitution treatment. This procedure results in successful survival of such patients for years. Chronic haemodialysis is accompanie...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SPb RAACI
2014-07-01
|
Series: | Medicinskaâ Immunologiâ |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/513 |
id |
doaj-b9f4b999df6742ceae3f4b1e2761a647 |
---|---|
record_format |
Article |
spelling |
doaj-b9f4b999df6742ceae3f4b1e2761a6472021-07-29T09:02:26ZrusSPb RAACIMedicinskaâ Immunologiâ1563-06252313-741X2014-07-01132-321121810.15789/1563-0625-2011-2-3-211-218510PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSISD. S. PolyakovO. M. DomashenkoP. V. BeloborodovK. A. SyssoevM. M. ShavlovskyAreg A. TotolianАbstract. Patients with end-stage renal disease need their kidney functions to be replaced. Chronic haemodialysis represents a most common method of such substitution treatment. This procedure results in successful survival of such patients for years. Chronic haemodialysis is accompanied by a complication which is known as β2-microglobulin amyloidosis. In this case, amyloid substance consisting of β2-microglobulin (β2-MG) accumulates in bones, ligaments and joints. Biological causes of β2-MG amyloidosis are still not established. To elucidate the role of inflammation in the pathogenesis of β2-MG amyloidosis, the levels of IL-2, IL-4, IL-6, IL-8, IL-10, GM-CSF, IFNγ, TNFα were quantified in plasma of patients undergoing long-term haemodialysis. Mean amounts of all the mentioned cytokines in haemodialysis patients proved to be significantly higher than in control group consisting of healthy subjects. When comparing a group receiving standard dialysis procedure versus a subgroup receiving haemodiafiltration, a single reliable difference was revealed for GM-CSF levels (p < 0.04), without any differences shown for other cytokines. With increasing terms of chronic haemodialysis, the levels of IL-2, IL-4, IL-6, IL-8, GM-CSF, IFNγ, TNFα were increased, or, at least, they did not decrease. After three years of dialysis, IL-10 concentrations were statistically indistinguishable from normal levels. In patients undergoing haemodiafiltration, plasma levels of IL-2, IL-4, IL-8, GM-CSF, IFNγ, TNFα did not drop with increasing terms of dialysis. The levels of IL-6 and IL-10 decreased after three years of dialysis, to near-normal levels.In general, these results suggest that IL-10 and IL-6 may be regarded as candidates for further studies as potential markers of β2-microglobulin amyloidosis. (Med. Immunol., 2011, vol. 13, N 2-3, pp 211-218)https://www.mimmun.ru/mimmun/article/view/513cytokineshaemodialysisinflammationβ2-microglobulinamyloidosis |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
D. S. Polyakov O. M. Domashenko P. V. Beloborodov K. A. Syssoev M. M. Shavlovsky Areg A. Totolian |
spellingShingle |
D. S. Polyakov O. M. Domashenko P. V. Beloborodov K. A. Syssoev M. M. Shavlovsky Areg A. Totolian PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS Medicinskaâ Immunologiâ cytokines haemodialysis inflammation β2-microglobulin amyloidosis |
author_facet |
D. S. Polyakov O. M. Domashenko P. V. Beloborodov K. A. Syssoev M. M. Shavlovsky Areg A. Totolian |
author_sort |
D. S. Polyakov |
title |
PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS |
title_short |
PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS |
title_full |
PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS |
title_fullStr |
PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS |
title_full_unstemmed |
PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS |
title_sort |
plasma cytokines levels in patients undergoing long-term haemodialysis |
publisher |
SPb RAACI |
series |
Medicinskaâ Immunologiâ |
issn |
1563-0625 2313-741X |
publishDate |
2014-07-01 |
description |
Аbstract. Patients with end-stage renal disease need their kidney functions to be replaced. Chronic haemodialysis represents a most common method of such substitution treatment. This procedure results in successful survival of such patients for years. Chronic haemodialysis is accompanied by a complication which is known as β2-microglobulin amyloidosis. In this case, amyloid substance consisting of β2-microglobulin (β2-MG) accumulates in bones, ligaments and joints. Biological causes of β2-MG amyloidosis are still not established. To elucidate the role of inflammation in the pathogenesis of β2-MG amyloidosis, the levels of IL-2, IL-4, IL-6, IL-8, IL-10, GM-CSF, IFNγ, TNFα were quantified in plasma of patients undergoing long-term haemodialysis. Mean amounts of all the mentioned cytokines in haemodialysis patients proved to be significantly higher than in control group consisting of healthy subjects. When comparing a group receiving standard dialysis procedure versus a subgroup receiving haemodiafiltration, a single reliable difference was revealed for GM-CSF levels (p < 0.04), without any differences shown for other cytokines. With increasing terms of chronic haemodialysis, the levels of IL-2, IL-4, IL-6, IL-8, GM-CSF, IFNγ, TNFα were increased, or, at least, they did not decrease. After three years of dialysis, IL-10 concentrations were statistically indistinguishable from normal levels. In patients undergoing haemodiafiltration, plasma levels of IL-2, IL-4, IL-8, GM-CSF, IFNγ, TNFα did not drop with increasing terms of dialysis. The levels of IL-6 and IL-10 decreased after three years of dialysis, to near-normal levels.In general, these results suggest that IL-10 and IL-6 may be regarded as candidates for further studies as potential markers of β2-microglobulin amyloidosis. (Med. Immunol., 2011, vol. 13, N 2-3, pp 211-218) |
topic |
cytokines haemodialysis inflammation β2-microglobulin amyloidosis |
url |
https://www.mimmun.ru/mimmun/article/view/513 |
work_keys_str_mv |
AT dspolyakov plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis AT omdomashenko plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis AT pvbeloborodov plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis AT kasyssoev plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis AT mmshavlovsky plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis AT aregatotolian plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis |
_version_ |
1721249982620631040 |